Immediate Impact
6 by Nobel laureates 57 standout
Citing Papers
Palliative Care for Patients With Cancer: ASCO Guideline Update
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Ratislav Bahleda being referenced
Results from the first-in-human (FIH) phase I study of RO5520985 (RG7221), a novel bispecific human anti-ANG-2/anti-VEGF-A antibody, administered as an intravenous infusion to patients with advanced solid tumors.
2014
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ratislav Bahleda | 115 | 165 | 213 | 126 | 31 | 449 | |
| C. Le Tourneau | 71 | 106 | 209 | 136 | 37 | 381 | |
| Begoña Jiménez | 168 | 167 | 264 | 113 | 28 | 501 | |
| Éric-Charles Antoine | 108 | 108 | 252 | 65 | 28 | 462 | |
| Jane C. Wright | 83 | 142 | 210 | 91 | 42 | 484 | |
| Joseph Gibbons | 70 | 101 | 189 | 173 | 17 | 477 | |
| Xuyang Song | 61 | 78 | 326 | 154 | 26 | 489 | |
| Mohamed A. Gouda | 202 | 152 | 199 | 150 | 57 | 467 | |
| Pasquale Lombardi | 103 | 116 | 222 | 139 | 41 | 454 | |
| K. Nathan Sankar | 74 | 112 | 247 | 155 | 38 | 462 | |
| Herb Kotz | 83 | 150 | 320 | 131 | 23 | 486 |
All Works
Loading papers...